Clinical Drug Investigation
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 54.5% | 0.823 | Q2 | 78.2% |
| 2024 | 2.7 | Q2 | 53.8% | 0.771 | Q2 | 76.8% |
| 2023 | 2.9 | Q2 | 59.1% | 0.680 | Q2 | 74.8% |
| 2022 | 3.2 | Q3 | 57.0% | 0.680 | Q2 | 75.9% |
| 2021 | 3.6 | Q3 | 61.3% | 0.718 | Q2 | 78.2% |
| 2020 | — | — | 0.739 | Q2 | 77.6% | |
| 2019 | — | — | 0.725 | Q2 | 77.8% | |
| 2018 | — | — | 0.731 | Q2 | 76.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1173-2563
ISSN
1179-1918
region
Western Europe
coverage
1995-2026